What is the recommended dose of Mylanta (aluminum hydroxide/magnesium hydroxide) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mylanta Dosing for Adults

For adults using Mylanta (aluminum hydroxide/magnesium hydroxide) as an antacid, the recommended dose is 5 to 15 mL (1 to 3 teaspoonfuls) taken as needed, not exceeding the maximum daily dose in a 24-hour period. 1

Standard Antacid Dosing

  • Adults and children 12 years and older: 5 to 15 mL (1 to 3 teaspoonfuls) per dose 1
  • Shake well before use and can be taken with water 1
  • Do not exceed the maximum recommended daily dose in a 24-hour period 1

Alternative Laxative Dosing (When Used for Constipation)

If using the magnesium hydroxide component specifically for laxative effect:

  • Adults and children 12 years and older: 30 mL (2 tablespoons) to 60 mL (4 tablespoons) once daily 1
  • Preferably taken at bedtime, in divided doses, or as directed by a physician 1
  • Maximum daily dose: 60 mL in a 24-hour period 1
  • Drink a full glass (8 oz) of liquid with each dose 1

Clinical Context from Guidelines

When magnesium hydroxide is used for opioid-induced constipation (a common clinical scenario), the National Comprehensive Cancer Network recommends:

  • 30-60 mL daily as an add-on agent when first-line laxatives are insufficient 2
  • This dosing is used after ruling out bowel obstruction and checking for impaction 2

Important Drug Interactions

  • Fluoroquinolones: Mylanta significantly reduces absorption of moxifloxacin and other fluoroquinolones 3
  • Administer Mylanta at least 4 hours after fluoroquinolone administration 3

Special Population Considerations

  • Elderly patients: May require dose reduction due to increased risk of side effects with aluminum-containing antacids 3
  • Renal impairment: Use caution, as aluminum can accumulate in the body with chronic use 3, 4
  • Long-term use without medical supervision may lead to phosphate depletion 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maalox Interactions and Special Populations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gaviscon Dosing and Safety Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dosing interval for Mylanta (aluminum hydroxide/magnesium hydroxide)?
Is Mylanta (aluminum hydroxide, magnesium hydroxide, simethicone) advised for a 14-year-old?
What is the recommended dosage of Mylanta (aluminum hydroxide, magnesium hydroxide, and simethicone) for adults and children over 12 years old?
What is the proper dosage and administration instructions for a PRN (as needed) order for Mylanta (aluminum hydroxide, magnesium hydroxide, and simethicone)?
What is the recommended dosage of Mylanta (aluminum hydroxide, magnesium hydroxide, simethicone) for adults and children over 12 years old?
What is the appropriate dose of Augmentin (amoxicillin/clavulanate) for a 5-year-old female patient weighing 54.2 pounds with pneumonia?
Is inclisiran (Leqvio) a suitable treatment option for a patient with dyslipidemia, statin intolerance, and elevated LDL-C level?
What are the diagnostic and treatment implications of a dim CD5+ (Cluster of Differentiation 5) monoclonal B-cell population with immunophenotypic characteristics CD19+ (Cluster of Differentiation 19), CD20+ (Cluster of Differentiation 20), CD5+ (dim), CD23- (Cluster of Differentiation 23), CD38+ (Cluster of Differentiation 38), CD200- (Cluster of Differentiation 200), FMC7+ (Fluorescence Monoclonal Clone 7), lambda-restricted, comprising 15% of total cells?
What is the diagnosis and management for a dim CD5+ (Cluster of Differentiation 5) monoclonal B-cell population detected in the thyroid, characterized by CD19+ (Cluster of Differentiation 19), CD20+ (Cluster of Differentiation 20), dim CD5+, CD23- (Cluster of Differentiation 23), CD38+ (Cluster of Differentiation 38), CD200- (Cluster of Differentiation 200), FMC7+ (Fluorescence Monoclonal Clone 7), and lambda-restricted light chain expression?
What is the recommended dosing interval for Mylanta (aluminum hydroxide/magnesium hydroxide)?
What is the treatment for acute angle closure glaucoma secondary to Topamax (topiramate)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.